Heart Test Laboratories (NASDAQ:HSCS – Get Rating) and Invacare (NYSE:IVCRQ – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.
Profitability
This table compares Heart Test Laboratories and Invacare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Heart Test Laboratories | N/A | N/A | -170.34% |
| Invacare | -16.72% | -94.34% | -10.81% |
Analyst Ratings
This is a breakdown of current ratings for Heart Test Laboratories and Invacare, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Heart Test Laboratories | 0 | 0 | 3 | 0 | 3.00 |
| Invacare | 0 | 0 | 0 | 0 | N/A |
Insider & Institutional Ownership
4.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 3.1% of Invacare shares are held by institutional investors. 14.6% of Heart Test Laboratories shares are held by insiders. Comparatively, 6.9% of Invacare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Heart Test Laboratories and Invacare’s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Heart Test Laboratories | $9,299.00 | 1,053.14 | -$4.83 million | N/A | N/A |
| Invacare | $741.73 million | 0.00 | -$101.07 million | N/A | N/A |
Heart Test Laboratories has higher earnings, but lower revenue than Invacare.
Summary
Heart Test Laboratories beats Invacare on 8 of the 10 factors compared between the two stocks.
About Heart Test Laboratories
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
About Invacare
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
